Telix Pharmaceuticals Limited Securities Fraud Class Action Lawsuit: Investors Encouraged to Inquire

Telix Pharmaceuticals Limited (TLX) has been sued for securities fraud. The lawsuit alleges that the company made false and misleading statements about its progress on prostate cancer therapeutic candidates and its supply chain quality. Investors who purchased TLX securities between February 21, 2025, and August 28, 2025, may be eligible to participate in the lawsuit. The deadline for filing a lead plaintiff motion is January 9, 2025.